BCEIE › News › KOTARISUG

M&A

Kothari Sugars And Chemicals: Receipt of Order passed by the Honble National Company Law Tribunal, Chennai Bench, in connection with the…

Kothari Sugars And Chemicals (KOTARISUG) filed a disclosure titled "Receipt of Order passed by the Honble National Company Law Tribunal, Chennai Bench, in connection with the proposed Scheme of Amalgamation directing the companies for convening…". The…

BCEIE News Desk · Published 5 Oct 2026, 09:20 pm IST · Filing received 5 Oct 2026, 09:04 pm IST

What happened

Kothari Sugars And Chemicals (KOTARISUG) filed a disclosure with the exchanges on 5 October 2026 at 09:04 PM titled "Receipt of Order passed by the Honble National Company Law Tribunal, Chennai Bench, in connection with the proposed Scheme of Amalgamation directing the companies for convening…".

From the filing: "Kothari Sugars And Chemicals Limited has informed the Exchange about the receipt of Order passed by the Honble National Company Law Tribunal, Chennai Bench, in connection with the proposed Scheme of Amalgamation directing the companies for convening the respective meetings of shareholders and…"

Company snapshot

Kothari Sugars And Chemicals is a micro-cap company, with a market value of about ₹214 crore.

The stock last traded at ₹25.83, against a 52-week range of ₹22.5–₹39.94 (35.3% below the high).

Before this filing the shares had moved −18.1% over the month and −0.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.13 crore.

Promoters held 73.53% at the end of Q1 FY27. Foreign institutions owned 0.15% and domestic institutions 0.49%.

Quarterly results (standalone, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY26671.20.15
Q2 FY2668-7.2-0.87
Q3 FY2670121.44
Q4 FY26420.60.08
Q1 FY27830.10.01

What history shows

BCEIE's records show 1 previous m&a filing from the company since May 2026.

Market-wide, 1,961 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Regulatory approvals, completion of the deal and its effect on revenue and margins.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.